GMP

European medical cannabis will shift from capricious flowers to quality oils as patients seek consistent and reliable medicines. Some manufacturers looking to supply Europe with competitively-priced medical cannabis are preparing for this…
Read More...

Portugal is quickly becoming a powerhouse in the medicinal cannabis field, but as regulations have changed to promote medical cannabis, major damage has been caused to Portugal’s industrial hemp farmers. In some ways, Portugal greatly…
Read More...

When it comes to products other than flowers, the CBD needs to be extracted from the plant matter and processed into a substance that’s clean, potent, and easily measured. If you’re trying to manufacture a product with a very…
Read More...

The European medical cannabis market is a tough nut to crack for Canadian cannabis firms who face a more stringent regulatory regime than at home. Aphria’s shares rose by more than 10% after it became the latest Canadian Licensed…
Read More...

Cannabidiol (CBD) is the most dominant, non-psychoactive cannabinoid found in the cannabis plant, and the methods for utilizing this compound are becoming increasingly technical. When it comes to products other than flowers, the CBD needs…
Read More...

Ananda Developments has unveiled the latest phase of its wide-ranging U.K. cannabis business strategy with moves to create domestic cultivation and extraction operations. Already involved in the wholesale vaping and events’…
Read More...